Adamas Pharmaceuticals

YTD

ALL

Why Robinhood?

You can watch ADMS and buy or sell other stocks, ETFs, and their options commission-free!

About ADMS

Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric.

CEO

Neil F. McFarlane

CEONeil F. McFarlane

Employees

—

Employees—

Headquarters

Emeryville, California

HeadquartersEmeryville, California

Founded

2000

Founded2000

Employees

—

Employees—

ADMS Key Statistics

Market cap

376.37M

Market cap376.37M

Price-Earnings ratio

-4.85

Price-Earnings ratio-4.85

Dividend yield

—

Dividend yield—

Average volume

964.73K

Average volume964.73K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$9.15

52 Week high$9.15

52 Week low

$4.02

52 Week low$4.02

People also own

Based on the portfolios of people who own ADMS. This list is generated using Robinhood data, and it’s not a recommendation.